Skip to main content

Epidemiologic and laboratory classification systems for paralytic poliomyelitis cases

  • Chapter
Measles and Poliomyelitis

Summary

Classification systems for poliomyelitis cases were first developed in industrialized countries to provide a uniform and standardized method to assign epidemiological categories to individual cases, particularly for vaccine-associated paralytic poliomyelitis cases. The classification of paralytic poliomyelitis cases follows individual case investigations that attempt to collect all available clinical, epidemiologic and laboratory information on each suspected poliomyelitis case. Many countries have convened expert review committees to evaluate, confirm and classify suspected poliomyelitis cases. In the United States, classification systems for paralytic poliomyelitis cases have been in use since 1976. The goals of regional elimination of polio myelitis from the Americas by the year 1990, and of global eradication of poliomyelitis by the year 2000, provide an additional impetus to extend classification systems to poliomyelitisendemic areas and to standardize methods for monitoring progress towards these eradication objectives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, Pallansch MA, Orenstein WA, Hinman AR (1992) Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 14:568–579

    Article  PubMed  CAS  Google Scholar 

  2. Kim-Farley RJ, Bart KJ, Schonberger LB, Orenstein WA, Nkowane BM, Hinman AR, Kew OM, Hatch MH, Kaplan JE (1984) Poliomyelitis in the U.S.A.: Virtual elimination of disease caused by wild virus. Lancet ii: 1315–1317

    Article  Google Scholar 

  3. Expanded Programme on Immunization (1992) Global overview of poliomyelitis. Geneva, Switzerland: World Health Organization, 1992 (Technical Commission Document 56.1)

    Google Scholar 

  4. Robertson SE, Chan C, Kim-Farley R, Ward N (1990) Worldwide status of poliomyelitis in 1986, 1987 and 1988, and plans for its global eradication by the year 2000. World Health Stat Q 43: 81–90

    Google Scholar 

  5. Horstmann DM, Quinn TC, Robbins FC (eds) (1984) International Symposium on Poliomyelitis Control. Rev Inf Dis 6 [Suppl]: 301–601

    Google Scholar 

  6. Nathanson N (1982) Eradication of poliomyelitis in the United States. Rev Inf Dis 4: 940–945

    Article  CAS  Google Scholar 

  7. Resolution of the 41st World Health Assembly (1988) Global Eradication of Poliomyelitis by the Year 2000. Geneva, Switzerland: World Health Organization (WHA 41.28)

    Google Scholar 

  8. Expanded Programme on Immunization (1991) EPI global overview. Geneva, Switzerland: World Health Organization (EPI/GAG/WP.l)

    Google Scholar 

  9. Hinman AR, Foege WH, de Quadros CA, Patriarca PA, Orenstein WA, Brink EW (1987) The case for global eradication of poliomyelitis. Bull WHO 65:835–840

    PubMed  CAS  Google Scholar 

  10. Sutter RW, Brink EW, Cochi SL, Kew OM, Orenstein WA, Biellik RJ, Hinman AR (1989) A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. AmJ Public Health 79:495–498

    Article  CAS  Google Scholar 

  11. Expanded Programme on Immunization (1989) Global poliomyelitis eradication by the year 2000. Manual for managers of immunization programmes. Geneva, Switzerland: World Health Organization (WHO/EPI/POLIO/89.1)

    Google Scholar 

  12. Centers for Disease Control (1990) Case definitions for public health surveillance. MMWR 39 (RR-13): 1–43

    Google Scholar 

  13. Biellik RJ, Bueno H, Olive JM, de Quadros C (1992) Poliomyelitis case confirmation: characteristics for use by national eradication programmes. Bull WHO 70: 79–84

    PubMed  CAS  Google Scholar 

  14. Andrus JK, de Quadros C, Olivé JM, Hull HF (1992) Screening for acute flaccid paralysis for polio eradication: Ways to improve specificity. Bull WHO 70: 591–596

    PubMed  CAS  Google Scholar 

  15. Dietz V, Lezana M, Sancho CG, Montesano R (1992) Predictors of poliomyelitis case confirmation at initial clinical evaluation: Implications for poliomyelitis eradication in the Americas. Int J Epidemiol 21: 800–806

    Article  PubMed  CAS  Google Scholar 

  16. Andrus JK, de Quadros CA, Olivé JM (1992) The surveillance challenge: Final stages of eradication of poliomyelitis in the Americas. MMWR 41: 21–26

    PubMed  CAS  Google Scholar 

  17. de Quadros CA, Andrus JK, Olivé JM, de Macedo CG (1992) Polio eradication from the Western hemisphere. Ann Rev Publ Health 13: 239–252

    Article  Google Scholar 

  18. Centers for Disease Control (1988) Guidelines for evaluating surveillance systems. MMWR 37: 1–18

    Google Scholar 

  19. Expanded Program on Immunization (1988) Polio eradication field guide. 2nd edition, Washington, DC: Pan American Health Organization (ISBN 92 75 13006X)

    Google Scholar 

  20. Wharton M (1992) Evaluation of weekly negative reporting of acute flaccid paralysis, Venezuela, 1991. PAHO Bull 14:4–5

    Google Scholar 

  21. Wright PF, Kim-Farley RJ, Robertson SE, Scott RM, Ward NA, Henderson RH (1991) Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med 325:1174–1179

    Article  Google Scholar 

  22. World Health Organization (1989) Laboratory support for poliomyelitis eradication: Memorandum from a WHO meeting. Bull WHO 67: 365–367

    Google Scholar 

  23. Expanded Programme on Immunization (1990) Global poliomyelitis eradication by the year 2000. Manual for the virological investigation of poliomyelitis. Geneva, Switzerland: World Health Organization (WHO/EPI/CDS/POLIO/90.1.)

    Google Scholar 

  24. Centers for Disease Control (1990) Update: Progress toward eradicating poliomyelitis from the Americas. MMWR 39: 557–561

    Google Scholar 

  25. de Quadros CA, Andrus JK, Olivé JM, da Silveira C, Eikhof RM, Carrasco P, Fitzsimmons JW, Pinheiro FP (1991) Eradication of poliomyelitis: progress in the Americas. Pediatr Infect Dis J 10: 222–229

    Article  PubMed  Google Scholar 

  26. Gear JHS (1984) Nonpolio causes of polio-like paralytic syndromes. Rev Infect Dis 6 [Suppl]: 379–384

    Article  Google Scholar 

  27. Melnick JL (1984) Enterovirus type 71 infections: A varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis 6 [Suppl]: 387–390

    Article  Google Scholar 

  28. Nkowane BM, Wassilak SG, Orenstein WA, Bart KJ, Schonberger LB, Hinman AR, KewOM (1987) Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 257: 1335–1340

    Article  PubMed  CAS  Google Scholar 

  29. Poliomyelitis Surveillance Summary: 1979. Atlanta, Centers for Disease Control, April 1981.

    Google Scholar 

  30. Schonberger LB, McGowan JE, Gregg MB (1976) Vaccine-associated poliomyelitis in the United States: 1961-1972. Am J Epidemiol 104: 202–211

    PubMed  CAS  Google Scholar 

  31. Nakano JH, Hatch MH, Thieme ML, Nottay B (1978) Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol 24: 178–206

    PubMed  CAS  Google Scholar 

  32. van Wezel AL, Hazendonk AG (1979) Intratypic serodifferentiation of poliomyelitis virus by strain-specific antisera. Intervirology 11: 2–8

    Article  PubMed  Google Scholar 

  33. Humphrey DD, Kew OM, Feorino PM (1982) Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses. Infect Immun 36: 841–843

    PubMed  CAS  Google Scholar 

  34. Minor PD, Schild GC, Ferguson M, Mackay A, Magrath DI, John A, Yates PJ, Spitz M (1982) Genetic and antigenic variation in type 3 polioviruses: Characterization of strains by monoclonal antibodies and Tl oligonucleotide mapping. J Gen Virol 61: 167–176

    Article  PubMed  CAS  Google Scholar 

  35. Crainic R, Couillin P, Blondel B, Cabau N, Boue A, Horodniceanu F (1983) Natural variation of poliovirus neutralization epitopes. Infect Immun 41: 1217–1225

    PubMed  CAS  Google Scholar 

  36. Osterhaus ADME, van Wezel AL, Hazendonk TG, Uytdehaag FGCM, van Asten 4JAAM, van Steenis B (1983) Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of poliovirus type 1 using monoclonal antibodies versus crossadsorbed antisera. Intervirology 20: 129–136

    Article  PubMed  CAS  Google Scholar 

  37. Kew OM, Nottay BK, Obijeski JF (1984) Applications of oligonucleotide fingerprinting to the identification of viruses. In: K. Maramorosch and K. Koprowski (eds). Methods in Virology. Academic Press, New York, 8:41–84

    Google Scholar 

  38. Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM (1987) Geographic distribution of wild poliovirus type 1 genotypes. Virology 160: 311–322

    Article  PubMed  CAS  Google Scholar 

  39. da Silva EE, Pallansch MA, Holloway BP, Cuoto Oliveira MJ, Schatzmayr HG, Kew OM (1991) Oligonucleotide probes for the detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology 32: 149–159

    PubMed  Google Scholar 

  40. Yang Chen-Fu, De L, Holloway BP, Pallansch MA, Kew OM (1991) Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res 20:159–179

    Article  Google Scholar 

  41. Hayward JC, Gillespie SM, Kaplan KM, Packer R, Pallansch M, Plotkin S, Schonberger LB (1989) Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr Infect Dis J 8:611–616

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag/Wien

About this chapter

Cite this chapter

Sutter, R.W., Cochi, S.L., Patriarca, P.A. (1993). Epidemiologic and laboratory classification systems for paralytic poliomyelitis cases. In: Kurstak, E. (eds) Measles and Poliomyelitis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9278-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9278-8_19

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82436-8

  • Online ISBN: 978-3-7091-9278-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics